Skip to main content
Premium Trial:

Request an Annual Quote

Dresdner Kleinwort Wasserstein Begins Coverage of Genomic Sector

NEW YORK, Sept. 26 - Dresdner Kleinwort Wasserstein has begun covering a handful of “special niche” genomic and proteomic companies, the financial company said on Wednesday.

The coverage, which will be led by analyst Charles C. Duncan, will include Celgene, CuraGen, Exelixis, Human Genome Sciences, Millennium Pharmaceuticals, Myriad Genetics, Tularik, and Vertex Pharmaceuticals. These all were rated a “Buy,” the company said in a statement. Two more companies, Celera Genomics and Sangamo BioSciences, were rated an “Add.”

Duncan, who directs Dresdner Kleinwort Wasserstein's Equity Research Division in New York, has identified these companies, which he explained in a statement “stand at a productivity inflection point.”

“These companies make up a small group of established firms that … have fully adopted the use of genomic information and the new tools of biology and … have shown early successes in establishing the potential for multiple product development—both of which are key to generating superior rates of return for investors over the coming years,” Duncan said.

“We are recommending investment in companies with excellent product development capabilities, a long list of product-oriented news flow, and truly exciting growth prospects. Moreover, as drug developers, these companies are relatively ‘recession-resistant,’” he added.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.